Abstract: Lactoferrin (Lf), a mammalian iron scavenging defense protein, constitutively is present in exocrine secretions that consistently are exposed to microbial flora: milk, tears, tubotympanum and nasal exudate, saliva, bronchial mucus, gastrointestinal fluids, cervicovaginal mucus, and seminal fluid. Additionally, Lf is promptly delivered by circulating neutrophils to sites of microbial invasion. At these sites, the protein effectively scavenges iron at pH values as low as 3.5.
INTRODUCTION
Lactoferrin (Lf), a mammalian natural defense iron scavenging bilobed glycoprotein (~80 kDa), is present in exocrine secretions that consistently are exposed to microbial flora: milk, tears, tubotympanum and nasal exudate, saliva, bronchial mucus, gastro-intestinal fluids, cervicovaginal mucus, and seminal fluid [1] [2] [3] [4] [5] . Additionally, Lf is a major component of the secondary granules of circulating polymorphonuclear neutrophils (PMNs). The apoprotein (<15% iron saturated) is released upon degranulation of the PMNs at sites of microbial and neoplastic cell assault. After clearing the invaded areas of "free" iron, the iron-saturated holoprotein is ferried by macrophages to the liver where the iron is deposited in hepatocytes to become sequestered in ferritin.
Healthy hosts maintain an iron withholding defense system designed to prevent accumulation of nonprotein-bound iron in extracellular fluids. Iron contributes to development of illness in several ways. Ferric ions are reduced by superoxide, and the ferrous product is reoxidized by peroxide to regenerate ferric ions and yield hydroxyl radicals. The latter attack all classes of macromolecules. Hydroxyl radicals can initiate lipid peroxidation, depolymerize polysaccharides, inactivate enzymes, and, not least, cause DNA strand breaks. Moreover, iron can serve as a readily available essential nutrient for invading bacterial, fungal, and protozoan organisms as well as for neoplastic cells.
In mammals, the principal components of the scavenging arm of the iron withholding defense system are transferrin (Tf) and lactoferrin [6] . Each protein can bind strongly two atoms per molecule. The two iron chelators function in a complementary manner continuously to purge body fluids of *Address correspondence to this author at the Biology Department, Jordan Hall 142, Indiana University, Bloomington, IN 47405, USA; Tel: (812) 336-5556; Fax: (812) 855-6705; E-mail: eweinber@indiana.edu "free" iron. Transferrin is responsible for keeping the environment devoid of "free" iron in serum, lymph and cerebrospinal fluid (CSF).
Unlike Tf, which releases iron as the pH value falls below 7.4, Lf effectively can scavenge and retain iron at pH values as low as 3.5. Accordingly, Lf acts as a broad spectrum antimicrobial iron chelator in body fluids in which the pH value is lowered by catabolic acids released from metabolically active invaders as well as from defense leukocytes. Moreover, in many of the sites of Lf activity, lysozyme (LZ), a digester of bacterial peptidoglycan, also is present. The synergistic action of Lf and LZ provide first line protection against microbial invasion.
In specific body sites, constitutive combinations of Lf and Tf are not employed. The affinity of Lf for iron is approximately 300 times greater than is that of Tf. Thus were Lf to be present continuously in serum or CSF, it likely would interfere with the second essential function of Tf, the transfer of nutritional iron among body cells and tissues. Indeed, the serum half life of Lf intravenously injected in monkeys is less than 90 minutes (personal communication, Agennix, Inc). The quite high concentration of Lf in tears, together with LZ, protects ocular tissues from growth of most bacterial pathogens. These two innate (non-antigen specific) proteins allow a much lesser need for secretory antibody (IgA) for antibacterial defense. Accordingly, possible scarring of ocular tissues due to antigen-antibody reactions is minimized.
Elevation of Lf in specific body fluids results from accumulation of degenerating neutrophils and is an early useful indicator of an inflammatory response to insult. In piglets injected i.v. with endotoxin, Lf rose in serum at a rate of 0.04 M/h [10] . Similarly, during the initial phase of human infection with Neisseria meningitidis, Lf increased in serum at a rate of 0.15 M/h [11] . The quantity of faecal Lf is a useful indicator of the level of intestinal inflammation due to Crohn's disease [12, 131 or bacterial infection [14] . Vaginal fluid Lf titers are markedly elevated in patients with trichomoniasis, candidiasis, or bacterial vaginosis [15] .
RECOMBINANT LACTOFERRIN PRODUCTS AS-SOCIATED WITH ACCELERATED R&D
During the past fifteen years, biological systems have been developed for the production of recombinant human, bovine, equine, and porcine lactoferrin ( Table 2) . Although some differences in glycosylation of the recombinant proteins has been noted, such biochemical activities as iron chelation, binding to Lf receptors, recognition by Lf antibodies, and antimicrobial potency are similar to those of native Lf molecules. 
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[27] [28] Besides its powerful iron scavenging ability, Lf might have additional useful medicinal attributes. Thus interest in determining possible nutraceutical/preservative/pharmaceutical uses of the natural product continues to accelerate. The ready availability of recombinant lactoferrin has contributed to the great increase in number of research and development studies ( Table 3) . Moreover, Lf also has been observed to inhibit attachment of bacteria to host tissues. For instance, apoLf drastically inhibited attachment of Prevotella nigrescens to hydroxy apatite; holoLf was inactive [31] . In marked contrast, however, attachment of Actinobacillus actinomycetecomitans to buccal epithelial cells was inhibited by holoLf but not by apoLf [32] . Nevertheless, it is well established that A. actinomycetecomitans is killed by low concentrations of apoLf whereas holoLf is inactive [33] .
A very important function of apoLf (but not holoLf) is the suppression of biofilm development by such bacteria as Pseudomonas aeruginosa [34] and Streptococcus mutans [35] . Biofilms are remarkably resistant to phagocytes, irnmunoglobulins, disinfectants and antibiotics. Bacterial conversion from vegetative growth to biofilm formation also can be suppressed by such other iron chelators as apotransferrin and deferoxamine [36] .
The ability of enteropathogenic strains of Escherichia coli to adhere [37] and of Shigella flexneri [38] and group A streptococci [39] to invade human cells is impaired by lactoferrin. The protein also attenuates virulence of Hemophilus influenzae [40] by cleaving and removing arginine-rich sequences of IgAl proteases and the Hap adhesin. Iron binding apparently is not involved in these antibacterial activities of Lf.
The antimicrobial action of many, but not all, groups of antibiotics is suppressed by iron [41] . Thus the inhibitory concentrations of vancomycin [42] , doxycycline [43] , rifampin [43, 44] , and chloramphenicol [44] , but not an aminoglycoside, gentamycin [44] , were lowered by Lf. In contrast, Lf depressed the antibiotic action of another aminoglycoside, tobramycin [44a] . The very troublesome renal tubular and oto-toxic effects of aminoglycoside drugs require iron [45] . It will be of interest to determine if apoLf could attenuate the kidney and auditory toxic effects of these products.
ANTIFUNGAL AND ANTIPROTOZOAN ACTIVITY
In tests with Candida albicans and Rhodotorula rubra, the fungistatic action of Lf in human milk was suppressed by iron [46] . Oral candidiasis is associated with impaired secretion of Lf by salivary glands. In one study, for example, patients had a decrease in LF of 65% as compared with that of healthy controls [47] .
As has been found with antibacterial antibiotics, apoLf can reduce in vitro inhibitory concentrations of antifungal drugs. The protein markedly lowered the minimal fungistatic quantities of fluconazole, as well as of amphotericin B and 5-flucytosine for clinical isolates of several Candida species [48] . Similarly, in tests with clinical isolates of Pneumocystis carinii, Lf exhibited strong synergism with each of minocycline, clarithromycin, and pyrimethamine [49] .
In some systems, Lf requires a metal for activity. For instance, macrophage killing of Trypanosoma cruzi mastigotes was enhanced by Lf combined either with iron or zinc [50] . These disparate metals apparently stabilized the protein molecule in an active physical conformation. HoloLf but not apoLf killed Plasmodium falciparum in human erythrocytes [51] . The authors proposed that iron destruction of host cell and protozoan membranes by generation of hydroxyl radicals was facilitated by the Lf carrier of the metal.
ANTIVIRAL ACTIVITY
Replication of a broad spectrum of RNA and DNA viruses in cell cultures can be suppressed by physiological concentrations of Lf. The antiviral action does not involve metal scavenging.
The protein generally is observed to compete with the virus for host cell receptors such as heparan sulfate [52] [53] [54] [55] [56] [57] [58] . Alternatively, a direct binding of Lf to viral particles has been observed [59, 60] . In some systems, Lf binds to both virus and host cells [6l, 62, 62a] . In any case, to be active, Lf must be present at the time of attempted entry of the virus into uninfected cells.
In replication of hantavirus in Vero E6 cells, the 50% inhibiting dose (ID 50 ) of bLf, if present one h prior to inoculation was 0.02 M; if added five days after viral inoculation, 32 M [63] . Similarly, in cultures of human embryonal rhabdomyosarcoma cells inoculated with enterovirus 71, bLF completely suppressed replication when present at 0-30 min. If added at 45 min, activity was reduced by 80%; after 120 min, the protein was inactive [64] .
Despite a 69% homology between bLf and hLf, molecular conformation might differ sufficiently to affect dose response. In the enterovirus study [64] , bLf was active at onetenth the required dose of hLf. In assays of adenovirus replication in Hep-2 cells [65] and CMV and HIV in MTH cells and fibroblasts [66] , respectively, bLf was active at one seventh and one half the dose of hLf.
Molecular conformation of Lf also can be altered by the degree of metal saturation as well as by the kind of metal. In a study of herpes simplex virus in Vero cells, the ID 50 of apo-bLf, holo-Fe-bLf, holo-Mn-bLf, and holo-Zn-bLf, respectively, was 0.36 M, 0.l5 M, 0.17, M, and 0.40 M [67] .
Inasmuch as antiviral activity of Lf essentially is lost after initial infection has occurred, therapeutic trials would likely give negative results. In contrast, in breast fed infants, daily intake of hLf might provide prophylactic protection for enteric cells against such ingested agents as rotavirus, enterovirus, and adenovirus.
In herpes simplex infection of mouse cornea, topical 1% bLf prior to virus inoculation suppressed plaque formation [68] . However, the protein was inactive if applied 24 h after inoculation. In a group of 45 patients with hepatitis C virus (HCV), bLf was fed for 8 wks at daily doses between 22 and 90 mmol/L. No cures were obtained [69] . In another study, 11 HCV patients received daily oral doses of bLf of 22-45 mmol/L [69a] . A decrease in alanine transaminase and HCV-RNA in sera occurred in 3 of 4 patients who had low pretreatment levels of HCV-RNA. No changes occurred in 7 patients who had high pre-treatment levels of HCV-RNA.
IMMUNOMODULATORY AND ANTINEOPLASTIC ACTIVITY
A profusion of examples of suppression and stimulation of inflammation and innate immune responses by LF have been recorded with a variety of proposed mechanisms of action. The latter are based on the two notable attributes of Lf: its potent iron chelating function and its widespread ability to bind to cell components. For instance, IL-12/IL-18-mediated proliferation and IFN-gamma secretion of Thl cells are very sensitive to intracellular iron concentration [70] and the inflammatory action of lipopolysaccharide (LPS) is neutralized by Lf binding to lipid A of the endotoxin [71] [72] [73] [74] . Representative illustrations of the versatility of LF are contained in Tables 4 and 5 .
The remarkably manifold immunomodulatory activities of Lf suggest that the protein might have antineoplastic utility. For example, in a recent study in mice, oral rhLf stimulated intestinal cells to increase production of IL-18 by 6-8 fold [96] . In this system, the increase in IL-18 was accompanied by a 3 fold elevation of splenic NK cells as well as an enhanced number of CD8+ T cells in blood. In a different Mice, given i.v. rhLf, challenged 1 day later with i.v. LPS Supression of serum TNF-alpha [80] Germ free piglets fed bLf, challenged with i.v. LPS Decreased mortality [81] Newborn mice fed b or hLf Supression of ileocecal endotoxin [82] Rodents, fed rhLf, challenged with oral NSAIDS Supression of intestinal bleeding [83] Rats, fed bLf, challenged with oral dextran sulfate Supression of colitis [84] Rats, fed bLf, challenged with oral Escherichia coli Decreased endotoxemia [85, 86] Rabbits, fed hLf, challenged with oral Shigella flexneri Supression of inflammatory enteritis [87] Cyclophosphamide-treated mice fed bLf Lymphocyte population restored & T cell mediated immune response reconstituted [93] Methotrexate-treated mice fed bLf Cell mediated response reconstituted [94] Hepatitis C patients fed bLf daily for three months Enhancement of serum level of Thl cytokines [95] laboratory, oral, but not intraperitoneal, administration of bLf markedly elevated IL-18 levels in small intestine and in serum [97] .
In the latter study, an increase in caspase-1 activity and IFN-gamma also was observed. Additionally, oral bLf was found to stimulate production of caspase-3 and 8 as well as a TNF receptor (fas) at the site of colon tumor formation [98] . These and other studies of antineoplastic action of Lf are summarized in Table 6 .
Angiogenesis is a well recognized requirement for tumor cell growth. Apo-bLf suppressed vascular endothelial growth factor-A angiogenesis but, unexpectedly, apo-hLf stimulated this system; holo-hLf was inactive [100] . The investigator has suggested that "systemically administered apo-hLf may promote collateral blood vessel formation at hypoxic sites in normal tissue, thus counteracting ischemia and infarction" [100] .
BONE REMODELING ACTIVITY
Persons with such iron loading disorders as hemochromatosis (HH), African siderosis, and thalassemia tend to develop osteoporosis. For example, in a group of 38 males (age 47 ± 9 yrs) with untreated HH confirmed phenotypically and genetically, 79% were osteopenic and 34% osteoporotic [101] . In a set of 50 native South African patients with osteoporosis and femoral neck fractures, 88% were markedly iron loaded [102] . In patients with beta-thalassemia, ironinduced osteoblast dysfunction and reduced bone density are observed often [102a] . Accordingly, apo-Lf might be considered for a possible role in restoration of iron balance to the bone remodeling system In a study of human CD14 selected cells committed toward osteoclasts, bLf inhibited bone resorbing activity [103] . Similarly, in mouse bone marrow culture, osteoclastogenesis was suppressed by apo-Lf [104] . Moreover, in cultures of rat or human osteoblast-like cells, apo-bLf substantially reduced apoptosis and markedly increased osteoblast proliferation [104] . Authors of the latter study have observed that Lf is anabolic to bone in vivo and they have suggested that the protein might be useful as a local agent to promote bone repair [104] .
PEPTIDE FRAGMENT ACTIVITY
Lactoferrin can be digested in vitro to yield peptide fragments of varying length. Some, between 4 and 47 residues, have been tested for biologic activity. The fragments of interest are cationic and lack iron binding activity. Rather, they are quite similar to defensins, host peptides approximately 29-35 amino acids in length that are produced naturally to fight infection. Release of Lf peptide fragments in vivo might occur upon exposure of the protein to gastric pepsin or to pepsin-like proteases within neutrophil phagolysosomes. However, the size and tertiary structure of such hypothetical products might differ considerably from those listed below that were obtained in vitro [105] .
Peptide fragments that have been examined vary substantially in antibacterial spectra. Lactoferricin B (LfcinB), consisting of 25 amino acid residues from the Nterminal lobe of bLf, inhibited some, but not all, tested strains at minimal concentrations of 0.3-150 g/m1 [106] . Increased ionic strength and inoculum density as well as acid pH values and mucin suppressed antibacterial action [l07]. Proteases of Escherichicoli and Staphlyococcus aureus lowered susceptibility to LfcinB [108] .
Variable action against E. coli and S. aureus also has been reported for a shortened derivative, LfcinB 17-3l and for an all D-amino acid counterpart of l7-31 [108] . An eleven amino acid amphipathic synthetic peptide homologous to a helical region on helix 1 of hLf has shown bactericidal activity against E. coli [109] . In an in vivo study, mice were fed peptides 16-40 or l8-40 thirty min after installation of 10 8 cells of E. coli into the urinary bladder [110] . Moderate killing of the inoculum was achieved in 2 h by peptide 18-40; intact LF was inactive in this system.
Various peptide fragments have been tested also for anticandidal activity. In in vitro studies, LfcinB was synergistic with fluconazole against azole-resistant but not against azole-susceptible strains [111] . A peptide of the first six amino acids of Lf additively increased the anti-candidal action of amphotericin B and miconazole [112] . Residues 268-284 in the Nl domain of bLf [113] and the first eleven residues of the N terminus of hLf [114] have been observed to be candicidal in the absence of antibiotics. Continuous administration of bLf or bLf pepsin hydrolysate, but not of LfcinB, in drinking water starting one day prior to infection, lowered the growth of Candida albicans in the oral cavity of mice [115] .
Culture systems tested for antiviral activity of Lf fragments include hepatitis C versus human hepatocytes [116] , cytomegalovirus versus human fibroblasts [117] , rotavirus Table 6 . Antineoplastic Activities of Lactoferrin
System
Response to Lf Ref.
Immunocompetent mice, injected with tumor cells, fed rhLf Suppression of mammary adenocarcinoma [96] Immunosuppressed mice, injected with tumor cells, fed rhLf Supression of squamous cell carcinoma [96] Azoxymethane-treated rats, fed bLf Supression of colon tumors [98] Nitrosamine-treated rats, fed bLf Suppression of colon carcinoma, esophageal papilloma, lung adenomas & carcinomas [99] Azoxymethane-treated rats, implanted with an intestinal bacterium that conatained an rhLf gene Suppression of formation of aberrant crypt foci [18] versus enterocyte-1ike cells [118] , polio virus versus monkey embryo kidney cells [119] , and calcivirus versus feline kidney cells [119] . Not unexpectedly, Lf fragments were less antiviral than was the intact protein in suppressing ability of viruses to attach and infect host cells.
Fragment 39-42 of bLf was observed to have anti inflammatory and analgesic action in rodents [120] . Feeding of either bLf or its pepsin hydrolysate to mice suppressed metastases of colon carcinoma cells, possibly by enhancement of IL-18 production in the intestinal epithelium [121] . Lactoferricin, but not bLf, exerted anti-tumor activity against a murine fibrosarcoma [122] .
POSSIBLE HAZARDOUS ACTIVITY
Inasmuch as hLf is a natural human product, it should be more immunocompatible than chemotherapeutic agents comprised either of microbial secondary metabolites or synthetic pharmaceuticals. Nevertheless, antibodies to endogenous Lf have been detected in patients who have such autoimmune disorders as systemic lupus erythematosis [123] and type 1 diabetes [124] .
In food products such as milk and mayonnaise, moderate quantities of apo Lf can be incorporated to provide antioxidant/iron chelating activity [125] . However, at higher concentrations, Lf was found to act as a pro-oxidant [125] .
Recombinant hLf is now available in transgenic rice grains. This product is potentially anti-infective when fed to domestic animals or humans. Unfortunately, the grains contain a twofold increase in iron over that of non-transformed rice [126] . Millions of persons throughout the world have life-threatening iron loading disorders. Clearly visible labeling of the sacks of transformed rice in relevant languages 
Nutraceuticals
Rice expressing Lf + LZ; fed to chicks Improvement in feed efficiency; replacement of antibiotics [144] Rice expressing Lf + LZ; fed to humans Prevention of acute diarrhea [22] rhLf + probiotic; fed to pre-term infants Prevention of necrotizing enterocolitis [145] rhLf added to formula; fed to infants Prevention of iron-induced oxidation in stored formula [146] Pear expression of bLf Prevention of bacterial fire blight [25] Rice expression of hLf Prevention of bacterial seedling blight [147] Preservatives bLf added to food-and drink-stored products; e.g., soy powder Prevention of iron-induced oxidation during storage [3] bLf sprayed on meat products Prevention of bacterial growth during storage [148] 
Pharmaceuticals
Topical rhLf Enhancement of wound healing [149] Topical bLf Promotion of bone repair [104] Topical bLf Suppression of oral candidiasis [150] Topical pH-buffered Lf Suppression of oral candidiasis [151] Topical bLf Suppression of feline stomatitis [152] Oral rhLf Enhancement of IL-18 in gut cells; suppression of tumor cell growth [96] Oral rhLf + i.p. cisplatinum Additive enhanced suppression of tumor cell growth [96] Oral apo-Lf Suppression of gut cell release of pro-inflammatory cytokines in ulcerative colitis [153] Oral apo-Lf + probiotic Suppression of overgrowth of enteric pathogens [82] Oral apo-Lf + antibiotic Enhancement of antibiotic efficacy [154] Intra-articular hLf entrapped in liposomes Suppression of joint inflammation [155] Cervical rhLf Suppression of infection-induced pre-term delivery [156] Vaginal activated Lf Suppression of candidal growth [157] Vaginal activated Lf + fluconazole Suppression of candidal growth [158] should be used to caution these persons to forgo consumption of the product [127] .
Another possible hazard of nutritional use of Lf is the ability of the protein to stimulate replication of human T cell leukemia virus [128] . This virus is transmitted vertically from mother to nursling via breast milk and horizontally by sexual contact. Samples of bLf, hLf and rhLf were comparably active in this system. Heat denatured Lf was inactive [128] .
Some protozoan and bacterial pathogens can obtain nutritional iron by binding to partially or completely iron saturated Lf molecules. Protozoa in this category include Tritrichomonas fetus [129] , Leishmania chagasi [130] , and Toxoplasma gondii [131] . A sexually transmitted protozoan in cattle, but not in humans, T. fetus binds bLf much more strongly than hLf [129] .
Among bacterial species that can access nutritional iron from Lf are members of the family Neisseriaceae [132] . For instance, the causative agent of infectious conjunctivitis in cattle, Moraxella bovis, utilizes bLf to obtain growth essential iron [133] . The majority of non-encapsulated strains of Hemophilus influenzae, derived from sputum in cases of human bronchitis, bind hLf for their source of iron [134] .
Other bacterial pathogens that can acquire iron from hLf include Legionella pneumophila [135] and Helicobacter pylori (136] . The latter organism is the major etiologic agent of chronic gastritis and peptic ulcer in humans and is a potential risk factor for gastric cancer. Cells of H. pylori form a 70 kDa hLf binding protein that enables them to acquire iron from human but not from bovine or equine lactoferrin [137] . The remarkably specific ecological niche of H. pylori in human gastric epithelium is a direct consequence of the availability of hLf and iron in gastric secretions.
The inability of H. pylori to obtain iron from bLf has permitted the latter to be a useful adjunct to the standard triple drugs employed in therapy of human patients [138] . As a corollary, hLf is effective in therapy of murine infection due to H. felis [139] . The latter pathogen apparently cannot obtain iron from hLf. In in vitro tests, H. pylori was found to be quite resistant to the antibacterial action of rhLf [140] . Moreover, in uncured patients with H. pylori infection, gastric juice levels of hLf were observed to be fourfold higher than in normal persons [141] . Thus it could be predicted readily that clinical trials of rhLf in treatment of H. pylori infections would be futile. Nevertheless, two such trials were conducted [142, 143] ; none of the subjects cleared the infection. In neither study were adverse effects observed. Apparently the gastric contents of the infected patients had a sufficient quantity of Lf to sustain maximal growth of the pathogen. Unfortunately, in neither study were the levels reported of endogenous lactoferrin or the amounts of nutritional and supplemental iron consumed by the subjects or controls.
NUTRACEUTICAL/ PRESERVATIVE/PHARMACEU-TICAL ACTIVITY
Generally in experimental systems in which bLf and hLf have been compared, biologic activity appears to be similar.
As cited above, however, bLf was more active than hLf in some antiviral models [64] [65] [66] . In patients infected with Helicobacter pylori bLf [138] but not hLf [142, 143] showed therapeutic activity. In one system, bLf and hLf had opposite actions; the former suppressed and the latter enhanced angiogenesis [100] .
In the development of apo-lactoferrin products for nutraceutical/ preservative/pharmaceutical applications, it will be important to be aware of the quantity of iron in the targeted sites. In some systems, the metal might neutralize the action of the protein; in others, iron might be required for activity. In still other systems, the powerful iron chelating action of Lf might reveal a hitherto unrecognized biological role of iron. Examples of potential applications of lactoferrin are contained in Table 7 . 
